Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
NCT07713875Phase 4Not yet recruiting
- Sponsor
- Oxford Nanopore
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by Oxford Nanopore. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT07713875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07713875.